[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367662-105":59,"doc-detail-367662-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","comprehensive-analysis-of-mutational-processes-across-20-000-adult-and-pediatric-tumors","Comprehensive analysis of mutational processes across 20 000 adult and pediatric tumors","","Mutational signature analysis is a mature practice in modern cancer genomics, yet it faces major challenges: inferring the number of signatures is heuristic-dependent, some signatures lack clear biological etiology, and outcomes depend strongly on the signature catalog used. RESOLVE introduces robust estimation of mutational signatures via regularization, enabling efficient extraction, assignment, and confidence estimation. Applied to 20 000 adult and pediatric samples, it characterizes cancer subtypes linked to mutational processes and driver gene alterations. RESOLVE fits mutations with fewer signatures than existing catalogs, supports a limited set of dominant processes, clusters patients by signature-defined groups, and associates signatures with prognosis and driver-gene mutations, informing mechanisms and evolution.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/comprehensive-analysis-of-mutational-processes-across-20-000-adult-and-pediatric-tumors/367662/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/comprehensive-analysis-of-mutational-processes-across-20-000-adult-and-pediatric-tumors/367662.png","ImageObject",300,407,{"name":92,"@type":93},"Cipher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What challenges does the paper identify in mutational signature analysis?","Question",{"text":112,"@type":113},"It highlights difficulty in determining the number of signatures, the existence of signatures without clear etiologies, and strong dependence of signature assignment on the chosen signature catalog.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is RESOLVE and what does it enable?",{"text":117,"@type":113},"RESOLVE is a regularization-based framework that supports efficient extraction, assignment, and confidence estimation of mutational signatures, and enables stratification of cancer genomes by active mutational processes.",{"name":119,"@type":110,"acceptedAnswer":120},"How were RESOLVE’s results validated or demonstrated?",{"text":121,"@type":113},"The framework was applied to 20 000 samples from adult and pediatric cancers, yielding comprehensive subtype characterization linked to specific mutational processes and driver gene alterations.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},367662,1790472052,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687208528416,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Nucleic Acids Research, 2025, 53, gkaf648 [https://doi.org/10.1093/nar/gkaf648](https://doi.org/10.1093/nar/gkaf648)  \nMethods  \nComprehensive analysis of mutational processes across 20 000 adult and pediatric tumors  \nMatteo Villa 1 ,†, Federica Malighetti 1 ,†, Luca De Sano2 , Alberto Maria Villa 1 , Nicoletta Cordani1 , Andrea Aroldi 1 ,3 , Marco Antoniotti 2 ,4 ,5 , Giulio Caravagna6 , Alex Graudenzi2 ,4 ,5 ,  \nRocco Piazza 1 ,3 , Luca Mologni 1 , Daniele Ramazzotti 1 ,3 ,4 , *  \n1 Department of Medicine and Surgery, University of Milano-Bicocca, Monza 20900, Italy  \n2 Department of Informatics, Systems and Communication, University of Milano-Bicocca, Milan 20126, Italy  \n3 Fondazione IRCCS San Gerardo dei Tintori, Monza 20900, Italy  \n4 Bicocca Bioinformatics, Biostatistics and Bioimaging Centre (B4), Milan 20854, Italy  \n5 Institute of Molecular Bioimaging and Physiology, Consiglio Nazionale delle Ricerche (IBFM-CNR), Segrate, Milan 20090, Italy  \n6 Department of Mathematics and Geosciences, University of Trieste, Trieste 34128, Italy  \n* To whom correspondence should be addressed. Email: [daniele.ramazzotti@unimib.it](daniele.ramazzotti@unimib.it)[ ](daniele.ramazzotti@unimib.it)†The first two authors should be regarded as Joint First Authors.  \nAbstract  \nDespite being a consolidated practice in modern cancer genomics, mutational signature analysis poses various challenges. First, determining the number of signatures is a complex task and depends on heuristics. Second, several signatures lack a clear etiology, raising concerns about whether they result from computational artifacts or actual mutagenic processes. Last, approaches for signature assignment are highly influenced by the catalogue of signatures used for the analysis. To overcome these limitations, we introduce RESOLVE ( Robust  EStimation Of mutationaL signatures Via rEgularization), a framework designed for the efficient extraction, assignment, and confidence estimation of mutational signatures. RESOLVE enables the stratification of cancer genomes according to the active mutational processes, providing insights into those that are consistently shared among various cancer types. We applied RESOLVE to 20 000 samples from adult and pediatric cancers, providing a comprehensive characterization of subtypes associated with specific mutational processes and alterations in driver genes. Our analysis demonstrates that RESOLVE accurately fits observed mutations with a smaller set of signatures compared to existing catalogues, suggesting the existence of a limited number of dominant mutational processes in cancer genomes. Clustering analysis revealed distinct patient groups characterized by specific signatures, with significant associations between certain signatures and patient prognosis. Additionally, we identified strong associations between signatures and driver gene mutations, offering insights into cancer subtype mechanisms and evolution. Our findings highlight the efficiency of RESOLVE and its potential impact on personalized cancer treatment.  \nGraphical abstract  \nReceived: October 23, 2024. Revised: May 31, 2025. Editorial Decision: June 13, 2025. Accepted: June 19, 2025  \n© The Author(s) 2025. Published by Oxford University Press on behalf of Nucleic Acids Research.  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License  \n([https:](https://creativecommons.org/licenses/by-nc/4.0/)[//](https://creativecommons.org/licenses/by-nc/4.0/)[creativecommons.org](https://creativecommons.org/licenses/by-nc/4.0/)[/](https://creativecommons.org/licenses/by-nc/4.0/)[licenses](https://creativecommons.org/licenses/by-nc/4.0/)[/](https://creativecommons.org/licenses/by-nc/4.0/)[by-nc](https://creativecommons.org/licenses/by-nc/4.0/)[/](https://creativecommons.org/licenses/by-nc/4.0/)[4.0](https://creativecommons.org/licenses/by-nc/4.0/)[/](https://creativecommons.org/licenses/by-nc/4.0/)), which permits non-comme","cbCaidaw895kw5js","https://ap.wps.com/l/cbCaidaw895kw5js","pdf",8874674,18,"English","# Methods\n## Comprehensive analysis of mutational processes across 20 000 adult and pediatric tumors\n# Abstract\n## RESOLVE framework and key findings\n# Introduction","[{\"question\":\"What challenges does the paper identify in mutational signature analysis?\",\"answer\":\"It highlights difficulty in determining the number of signatures, the existence of signatures without clear etiologies, and strong dependence of signature assignment on the chosen signature catalog.\"},{\"question\":\"What is RESOLVE and what does it enable?\",\"answer\":\"RESOLVE is a regularization-based framework that supports efficient extraction, assignment, and confidence estimation of mutational signatures, and enables stratification of cancer genomes by active mutational processes.\"},{\"question\":\"How were RESOLVE’s results validated or demonstrated?\",\"answer\":\"The framework was applied to 20 000 samples from adult and pediatric cancers, yielding comprehensive subtype characterization linked to specific mutational processes and driver gene alterations.\"}]","Comprehensive analysis of mutational processes across 20 000 adult and pediatric tumors | PDF",1790171840,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f27585882d047c708df7d9114e63b99b.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da60670ead4b0f4d8e335c3ef16a034e.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e60d72e5b0282bdb33f148bd999ab2d9.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/106fddb0d49ad32532bd3ca69aa5ad73.webp",980,1268]